|
HS Code |
122806 |
| Product Name | Bovine Bone Chondroitin Sulfate |
| Source | Bovine bone |
| Appearance | White to off-white powder |
| Purity | ≥ 90% |
| Solubility | Soluble in water |
| Molecular Weight | 10,000–50,000 Da |
| Odor | Odorless |
| Identification Method | HPLC or FTIR |
| Ph Value | 5.5–7.5 (1% solution) |
| Loss On Drying | ≤ 10% |
| Residue On Ignition | ≤ 15% |
| Storage Conditions | Cool, dry place away from light |
| Cas Number | 9007-28-7 |
| Protein Content | ≤ 6.0% |
| Heavy Metals | < 10 ppm |
As an accredited Bovine Bone Chondroitin Sulfate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, sealed plastic drum containing 25 kg of Bovine Bone Chondroitin Sulfate powder, labeled with product name, batch number, and manufacturer. |
| Shipping | **Shipping Description for Bovine Bone Chondroitin Sulfate:** Bovine Bone Chondroitin Sulfate is securely packaged in sealed, moisture-proof bags or drums. Store and transport in cool, dry conditions, away from direct sunlight and incompatible substances. Label as non-hazardous, but handle with care to prevent contamination. Complies with standard chemical shipping regulations. |
| Storage | Bovine Bone Chondroitin Sulfate should be stored in a tightly sealed container, protected from moisture, light, and heat. Keep the storage area cool and dry, ideally at room temperature (15–25°C). Avoid exposure to air and contaminants to maintain its stability and quality. Store away from incompatible substances and follow all safety and handling guidelines. |
| Purity 95%: Bovine Bone Chondroitin Sulfate with a purity of 95% is used in pharmaceutical tablet formulation, where it ensures consistent bioavailability and therapeutic efficacy. Molecular Weight 20 kDa: Bovine Bone Chondroitin Sulfate with a molecular weight of 20 kDa is used in injectable osteoarthritis treatments, where it promotes improved joint lubrication and patient mobility. Viscosity Grade 35 mPa·s: Bovine Bone Chondroitin Sulfate with a viscosity grade of 35 mPa·s is used in ophthalmic solutions, where it provides superior tear film stability. Particle Size < 100 μm: Bovine Bone Chondroitin Sulfate with a particle size below 100 μm is used in nutritional supplement powders, where it enhances dissolution rate and absorption. Stability Temperature up to 50°C: Bovine Bone Chondroitin Sulfate with stability up to 50°C is used in high-temperature food processing, where it maintains structural integrity and bioactivity. Sulfation Rate 85%: Bovine Bone Chondroitin Sulfate with a sulfation rate of 85% is used in cosmetic skin creams, where it increases skin hydration and elasticity. Loss on Drying ≤ 10%: Bovine Bone Chondroitin Sulfate with a loss on drying of less than or equal to 10% is used in softgel encapsulation, where it improves product stability and shelf life. |
Competitive Bovine Bone Chondroitin Sulfate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In the chemical manufacturing industry, the journey of any raw material shapes its quality long before it reaches the end user. Bovine bone chondroitin sulfate comes directly from bovine cartilage, obtained through a meticulous extraction process refined over years of practice and adjustment on our factory floors. This compound, a sulfated glycosaminoglycan, is recognized for supporting joint health and contributing to a range of applications, primarily in food supplements and pharmaceuticals. Our focus remains on transparency, traceability, and purity because we see every stage, from animal selection to final drying and milling, as opportunities to improve the product.
Every batch begins with the selection of raw bovine bones with clear documentation regarding animal health and origin. We work with food-grade material, following rigorous screening before processing. The chondroitin sulfate we produce consistently meets established USP and EP purity standards, with SO4 content usually exceeding 90% and low moisture levels to prolong shelf stability. We maintain a tight grip on particle size during milling, which ensures good solubility and easy handling for downstream processing in tablet or capsule form. Our team runs routine tests for heavy metal residues, protein content, and microbiological safety, making certain every drum we fill meets our uncompromising requirements. As a manufacturer, we see these controls not as hurdles, but as a responsibility to every customer using our ingredient for consumer health products.
Daily work in the plant reveals the complexity behind what appears in the industry as a simple white powder. Chondroitin sulfate production uses enzymatic hydrolysis, followed by a series of precipitation and purification steps. This isn’t a one-size-fits-all procedure. Temperature, time, solvent concentration, and pH each influence the final output, and real-world experience teaches more than any literature. Our operators adjust protocols based on subtle changes in raw material, avoiding degraded chains or unwanted side-products that can result from shortcutting critical steps. The hands-on nature defines not only the product’s physical properties, such as odor, moisture, and bulk density, but also its biochemical profile, affecting sulphation patterns and chain lengths. These factors impact both clinical outcomes and regulatory acceptance across different countries.
Compared to chondroitin sulfate derived from shark cartilage or porcine trachea, the bovine bone source stands out for several reasons. Sourcing bovine raw material aligns with a robust, well-established supply chain, allowing for predictable, year-round production. Shark-sourced material faces growing scrutiny over sustainability, traceability, and ethical concerns. Porcine-derived chondroitin finds use in regions with greater acceptance of pork byproducts, but bovine bone remains the ingredient of choice where versatility and dietary restrictions come into play. Customers in the pharmaceutical and food industries often seek bovine bone chondroitin sulfate because of its better record for allergen management and the stability in batch-to-batch supply.
Most orders land with us from companies producing joint health supplements, animal nutrition products, and specialty formulations for wound care or ophthalmic solutions. Manufacturing these products depends on ingredients that deliver as promised—chemically consistent, microbiologically safe, and physically manageable. That means predictable dissolution, controlled particle size—not too coarse for capsules, never fine enough to cause dusting problems on high-speed lines. Over time, we found that medical device manufacturers demand even stricter endotoxin and protein controls, which influenced upgrades in our purification line. Each sector places unique pressures on the ingredient, so we respond by listening to processors and labs, learning where generic batches fall short, and adopting practices that exceed regulatory thresholds.
Any manufacturer working with animal byproducts is aware of the pressure for transparency. Over the years, global trade brought us more stringent identification requirements and greater attention to animal origin. We record every shipment back to the farm, keep full traceability documents, and conduct regular audits of the slaughterhouse partners we depend on. Regulatory inspection is a part of this business, but thorough documentation also helps us trace back the cause of any abnormality in the final chondroitin sulfate—whether it be color, odor, or metal content. Direct sourcing from abattoirs with strong veterinary controls reduces risks related to bovine spongiform encephalopathy or unapproved veterinary drug residues. Few things matter more to ingredient buyers than the ability to prove that each lot comes from healthy animals and compliant facilities, something we safeguard with both paperwork and periodic third-party verification.
Chondroitin sulfate extraction is not frozen in time—equipment, process scale, and market requirements shift constantly. Years ago, we handled several manual precipitation steps; now, automated centrifuges and membrane filtration play key roles in refining the product. In-line quality control saves time but does not replace the tactile experience of checking powder feel, color, and bulk weight. Enzyme selection and process optimization, including temperature ramping and controlled stirring speeds, have allowed us to push recovery yields higher without sacrificing key quality benchmarks. Feedback from capsule manufacturers led us to recalibrate particle size distributors. Pharmaceutical clients expressed concerns over residual solvents, so we invested in advanced drying technologies that reduce both process times and potential contaminants.
Differences between chondroitin sulfate products often come down to how and where they are made. Shark-based products vary widely in molecular weight, sometimes impacting absorption or causing additional regulatory questions. Bovine bone material poses less risk of marine contaminants and generally falls within a preferred molecular weight range for supplement companies. Some market players deliver chondroitin blends using recycled or mixed sources, but our single-source approach lets us answer questions confidently. Consistent color and odor reduction distinguish a dedicated process from a rushed extraction line. End users notice when downstream issues like disintegration or binding problems pop up, but we've seen those decline dramatically once our customers adopt bovine bone chondroitin sulfate made under integrated controls.
Supplying pharmaceutical ingredients is about more than hitting a purity number on a certificate of analysis. Years of on-the-ground production have taught our team where adulteration risks arise. Some sources try to cut corners with added fillers or substitutions, but internal batch testing using spectroscopic and chromatographic techniques detects any off-profile spikes. Heavy metals, microbiological counts, and specified protein content all come under strict scrutiny before product release. Each week, our in-house lab pulls retention samples for trending. If a deviation appears, such as rising ash content or hint of residual protein, we halt shipment and backtrack the entire process, so mistakes never reach the customer. Raw material seasonality sometimes causes marginal shifts in profile, so we maintain a robust in-process adjustment practice to guarantee that product specifications stay tight year-round.
Over the years, our strongest process improvements started with customer conversations. Technical groups from supplement companies and contract manufacturers sent questions about powder flow or gel strength. Veterinary product makers flagged the importance of batch-to-batch consistency, especially when working with injectable formulations. Sharing data openly gave us ideas for equipment upgrades and method changes. Direct relationships, not just certificates, build mutual trust. Real challenges, such as adjusting the sulfation pattern or maintaining high purity even as average molecular weight increases, drive everyday decisions inside our facility. Unfiltered customer feedback pushes us to pilot new approaches and retire aging equipment, all aimed at raising the performance and reliability bar.
Bovine bone chondroitin sulfate sits at the intersection of nutraceutical, pharmaceutical, and food safety legislation. Jurisdictions differ on residue limits, labeling, and permitted uses, so we make regulatory review part of regular training for our staff. Audits from authorities and third-party quality agencies hold us to strict standards. Our compliance team cross-references international requirements, ensuring each batch fits both domestic and global applications. We maintain clear separation of non-GMO and non-allergen product lines for markets with heightened regulatory demands. As regulations evolve, we proactively adjust protocols and communicate with customers—supporting everything from import documentation to on-site audits.
Global demand for joint health products pushes some players toward dilution and mislabeling. Chondroitin sulfate, as a high-value target, draws attention from producers looking to substitute cheaper animal sources or blend in unidentified materials to inflate yields. Inside our factory, extensive identification tests on both incoming bones and finished lots keep adulteration out. Authenticity comes through repeated batch fingerprinting and active monitoring of supplier records. Cutting corners is not an option here; work done properly, from start to finish, gives our product a reputation for genuine content and traceable origin.
Across decades, studies have shown bovine bone chondroitin sulfate supports joint comfort and cartilage maintenance. Real-world data reflects benefits in osteoarthritis support and as an adjunct ingredient in specialty food items. Not every customer requests clinical data, but we monitor published research and support collaborative testing on new product formats. To back our claims, we provide detailed technical documentation with every lot, and can supply additional information on request, such as heavy metals, pesticide residues, and microbial control records.
We view bovine bone chondroitin sulfate as a value-added byproduct of the food industry, turning what could be waste into a meaningful health ingredient. Our procurement focuses on local and regional slaughterhouses, cutting down on the carbon footprint of transport and assuring greater material control. Sustainability also depends on maximizing yield per unit processed, which influences solvent recovery, water usage, and energy input inside the plant. Efforts to minimize resource consumption per finished kilogram, together with responsible waste management, represent our contribution to an industry working toward greener practices. We avoid endangered animal sources and follow best practices for animal welfare by maintaining strict supplier selection and periodic field audits.
Growth in demand for natural joint remedies, alongside regulatory scrutiny, continues to push manufacturers toward higher specification, traceable ingredients. Formulators look for straightforward labeling, such as “bovine source,” and integrate QR code solutions for end-user traceability. Our customers also drive a shift toward lower allergen risk and clean label status. We respond by streamlining cleaning protocols, eliminating cross-contamination between animal species, and refining specifications to suit next-generation supplement formats—chewables, gummies, and functional beverages. Collaboration with trends in vegan alternatives further encourages us to keep a transparent conversation about what animal-sourced chondroitin can and cannot deliver, respecting both scientific and consumer expectations.
We’ve learned that a proactive approach beats reactive fixes every time. In our plant, production managers check for any unusual powder color or faint off-odor during drying. By stopping processes at the first sign of deviation, we minimize loss and keep off-grade material out of shipment. Common issues—agglomeration, incomplete solubilization in blends, or excessive fines—respond best to mechanical or process adjustments at the production stage, not patchwork fixes in the warehouse. Regular dialogue with equipment suppliers and process engineers keeps our technology current and helps to solve problems before they reach a customer’s filling line.
Handling every step from bone delivery to final drum gives us control not only over product characteristics, but also over the reliability of every order placed. As a direct manufacturer, we stand by every certificate issued and back every shipment with both data and lived expertise. Our staff, many with years if not decades of experience, can diagnose common process hiccups, recommend handling solutions, and discuss real-world challenges unique to supplement and pharmaceutical companies. This front-line experience means we troubleshoot problems directly, update processes with minimal delay, and supply supporting data as new regulations or customer requirements emerge.
Consumer demand for traceable, pure, and well-characterized ingredients grows year by year. Technologies such as blockchain-based tracking, digital lot certificates, and rapid in-line testing support our goal of making the sourcing and manufacture of bovine bone chondroitin sulfate transparent. The days of generic commodity trading have given way to tailored partnerships, and as a manufacturer, we thrive on building these relationships with buyers, developers, and quality assurance teams. We invest in both human skill development and technical upgrades, staying ahead of market expectations in a fast-changing field. By keeping all manufacturing under one roof, with regular feedback from clients and partners, we can adapt and evolve quickly, delivering consistent results in every shipment.
From early morning materials delivery to late-night shift handovers, the team’s focus never drifts from the core goal: reliable, traceable, and safe chondroitin sulfate from bovine bone. Years of process improvement, direct customer engagement, and real-world troubleshooting lift the quality above industry baseline. Every drum sent out tells the story of its source, its careful processing, and its commitments—made by a manufacturer with a deep sense of responsibility to the people and companies who use it. Ingredients may begin with raw material, but it’s the process, oversight, and relationships at each step that set one product apart from another.